Balaxi Pharmaceuticals Limited
NSE:BALAXI.NS
88.32 (INR) • At close November 4, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -23.869 | 569.223 | 545.223 | 443.293 | 88.737 | 24.394 | -7.699 | -7.896 | -1.163 | 1.471 | 1.095 | 0.442 |
| Afschrijvingen & Amortisatie
| 20.984 | 17.525 | 5.122 | 2.978 | 0.075 | 0.035 | 0.02 | 0.014 | 0.022 | 0.017 | 0.004 | 0.006 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| 106.754 | -467.877 | -159.659 | -411.39 | -221.191 | -39.409 | 0.876 | -2.011 | -1.158 | 2.529 | -2.007 | -0.097 |
| Vorderingen
| -64.884 | -249.736 | 465.12 | -461.674 | -242.406 | -57.637 | 0 | 0.02 | 0.018 | 2.98 | -2.007 | -0.097 |
| Voorraden
| 228.553 | -63.197 | -850.857 | -127.858 | -8.321 | 0.006 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| -54.808 | -145.953 | 274.068 | 191.462 | 27.666 | 19.857 | 0.899 | -0.005 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| -2.107 | -8.991 | -47.99 | -13.32 | 1.87 | -1.636 | -0.034 | -0.004 | 0 | 0 | 0 | 0 |
| Overige Niet-Contante Posten
| -137.359 | -58.118 | -49.241 | -34.849 | -8.236 | -0.09 | 0.02 | -0.019 | 1.141 | -1.904 | -1.486 | 2.894 |
| Kasstroom uit Operationele Activiteiten
| 33.403 | 60.753 | 341.445 | 0.032 | -140.615 | -15.07 | -6.783 | -9.912 | -1.158 | 2.112 | -2.394 | 3.245 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -15.695 | -149.799 | -273.443 | -25.564 | -1.827 | -0.054 | -0.106 | 0 | -0.038 | -0.03 | 0 | 0 |
| Netto Overnames
| 5.232 | -19.215 | 34.164 | -33.659 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 19.215 | -34.164 | -34.164 | 0 | 0 | 0 | 0 | 0 | -32.257 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 34.164 | 34.164 | 34.164 | 0 | 0 | 0 | 32.88 | 0 | 0.421 | 0 | 0 |
| Overige Investeringsactiviteiten
| -8.768 | 9.981 | -45.204 | -0.505 | 0 | 0 | 0 | 0.019 | 0.016 | 0.754 | 3.286 | -0.485 |
| Kasstroom uit Investeringsactiviteiten
| -10.464 | -105.654 | -284.483 | -59.728 | -1.827 | -0.054 | -0.106 | 32.899 | -0.022 | -31.112 | 3.286 | -0.485 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| -60.402 | -0.211 | -0.211 | -0.211 | 0 | 0 | 0 | -2.021 | 0 | 0 | 0 | -2.15 |
| Uitgifte van Gewone Aandelen
| 257.901 | 184.713 | 184.713 | 180.96 | 180.96 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0.211 | -179.729 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | -4.984 | 0 | 0 | 0 | 0 | 0 | 0 | -1.1 | -0.819 | -0.732 | -0.814 |
| Overige Financieringsactiviteiten
| 0.433 | 75.397 | -1.417 | -144.288 | 180.96 | 0 | 0 | -2.433 | 0 | 24.57 | 0 | -2.15 |
| Kasstroom uit Financieringsactiviteiten
| 317.798 | 255.126 | -1.628 | 36.461 | 180.96 | 0 | 0 | -2.021 | -1.1 | 23.751 | -0.732 | -2.964 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | -0.001 | 0.255 | 0.255 | 0 | 0 | 0 | 0 | 0 | 0 | 5.512 |
| Netto Kasstroomverandering
| 340.738 | 210.225 | 55.333 | -23.235 | 38.772 | -15.124 | -6.889 | 22.987 | -1.179 | -5.248 | 0.159 | 5.309 |
| Kaspositie aan het Einde van de Periode
| 622.906 | 282.122 | 71.898 | 16.565 | 39.8 | 1.028 | 16.152 | 23.038 | -0.96 | 0.22 | 5.468 | 5.309 |